Search Results

There are 57810 results for: content related to: An exact method for analysis following a two-stage phase II cancer clinical trial

  1. A flexible multi-stage design for phase II oncology trials

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 369–373, Ming T. Tan and Xiaoping Xiong

    Version of Record online : 8 DEC 2010, DOI: 10.1002/pst.478

  2. Two-Stage Designs for Gene–Disease Association Studies with Sample Size Constraints

    Biometrics

    Volume 60, Issue 3, September 2004, Pages: 589–597, Jaya M. Satagopan, E. S. Venkatraman and Colin B. Begg

    Version of Record online : 27 AUG 2004, DOI: 10.1111/j.0006-341X.2004.00207.x

  3. A randomized two-stage design for phase II clinical trials based on a Bayesian predictive approach

    Statistics in Medicine

    Volume 34, Issue 6, 15 March 2015, Pages: 1059–1078, Matteo Cellamare and Valeria Sambucini

    Version of Record online : 29 DEC 2014, DOI: 10.1002/sim.6396

  4. Optimal three-stage designs for phase II cancer clinical trials

    Statistics in Medicine

    Volume 16, Issue 23, 15 December 1997, Pages: 2701–2711, T. Timothy Chen

    Version of Record online : 4 DEC 1998, DOI: 10.1002/(SICI)1097-0258(19971215)16:23<2701::AID-SIM704>3.0.CO;2-1

  5. On Simon's two-stage design for single-arm phase IIA cancer clinical trials under Beta-binomial distribution

    Statistics in Medicine

    Volume 29, Issue 10, 10 May 2010, Pages: 1084–1095, Junfeng Liu, Yong Lin and Weichung Joe Shih

    Version of Record online : 14 JAN 2010, DOI: 10.1002/sim.3805

  6. Simple Sequential Boundaries for Treatment Selection in Multi-Armed Randomized Clinical Trials with a Control

    Biometrics

    Volume 64, Issue 3, September 2008, Pages: 940–949, Ying Kuen Cheung

    Version of Record online : 26 OCT 2007, DOI: 10.1111/j.1541-0420.2007.00929.x

  7. Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies

    Genetic Epidemiology

    Volume 35, Issue 8, December 2011, Pages: 790–799, Dalin Li, Juan Pablo Lewinger, William J. Gauderman, Cassandra Elizabeth Murcray and David Conti

    Version of Record online : 15 SEP 2011, DOI: 10.1002/gepi.20628

  8. Two-stage design for dose-finding that accounts for both efficacy and safety

    Statistics in Medicine

    Volume 27, Issue 25, 10 November 2008, Pages: 5156–5176, Vladimir Dragalin, Valerii V. Fedorov and Yuehui Wu

    Version of Record online : 4 AUG 2008, DOI: 10.1002/sim.3356

  9. Randomized phase II trials with a prospective control

    Statistics in Medicine

    Volume 27, Issue 4, 20 February 2008, Pages: 568–583, Sin-Ho Jung

    Version of Record online : 15 JUN 2007, DOI: 10.1002/sim.2961

  10. A design of phase II cancer trials using total and complete response endpoints

    Statistics in Medicine

    Volume 24, Issue 20, 30 October 2005, Pages: 3155–3170, Ying Lu, Hua Jin and Kathleen R. Lamborn

    Version of Record online : 27 SEP 2005, DOI: 10.1002/sim.2188

  11. Two-stage designs for Phase 2 dose-finding trials

    Statistics in Medicine

    Volume 31, Issue 24, 30 October 2012, Pages: 2872–2881, Anastasia Ivanova, Changfu Xiao and Yevgen Tymofyeyev

    Version of Record online : 1 AUG 2012, DOI: 10.1002/sim.5365

  12. Endogenous Adaptation: The Effects of Technology Position and Planning Mode on IT-Enabled Change

    Decision Sciences

    Volume 37, Issue 3, August 2006, Pages: 325–355, Victoria L. Mitchell and Robert W. Zmud

    Version of Record online : 9 OCT 2006, DOI: 10.1111/j.1540-5414.2006.00130.x

  13. Curtailed two-stage designs with two dependent binary endpoints

    Pharmaceutical Statistics

    Volume 11, Issue 1, January/February 2012, Pages: 57–62, Chia-Min Chen and Yunchan Chi

    Version of Record online : 8 DEC 2011, DOI: 10.1002/pst.496

  14. Repeated significance tests of linear combinations of sensitivity and specificity of a diagnostic biomarker

    Statistics in Medicine

    Volume 35, Issue 19, 30 August 2016, Pages: 3397–3412, Mixia Wu, Yu Shu, Zhaohai Li and Aiyi Liu

    Version of Record online : 7 MAR 2016, DOI: 10.1002/sim.6932

  15. An evaluation of phase I clinical trial designs in the continuous dose–response setting

    Statistics in Medicine

    Volume 20, Issue 16, 30 August 2001, Pages: 2399–2408, Barry E. Storer

    Version of Record online : 10 AUG 2001, DOI: 10.1002/sim.903

  16. Optimal Design for the Precise Estimation of an Interaction Threshold: The Impact of Exposure to a Mixture of 18 Polyhalogenated Aromatic Hydrocarbons

    Risk Analysis

    Volume 32, Issue 10, October 2012, Pages: 1784–1797, Sharon D. Yeatts, Chris Gennings and Kevin M. Crofton

    Version of Record online : 28 MAY 2012, DOI: 10.1111/j.1539-6924.2012.01834.x

  17. Optimal adaptive two-stage designs for phase II cancer clinical trials

    Biometrical Journal

    Volume 55, Issue 6, November 2013, Pages: 955–968, Stefan Englert and Meinhard Kieser

    Version of Record online : 19 JUL 2013, DOI: 10.1002/bimj.201200220

  18. Two-Stage Designs for Gene–Disease Association Studies

    Biometrics

    Volume 58, Issue 1, March 2002, Pages: 163–170, Jaya M. Satagopan, David A. Verbel, E. S. Venkatraman, Kenneth E. Offit and Colin B. Begg

    Version of Record online : 21 MAY 2004, DOI: 10.1111/j.0006-341X.2002.00163.x

  19. Optimized multi-stage designs controlling the false discovery or the family-wise error rate

    Statistics in Medicine

    Volume 27, Issue 21, 20 September 2008, Pages: 4145–4160, Sonja Zehetmayer, Peter Bauer and Martin Posch

    Version of Record online : 28 APR 2008, DOI: 10.1002/sim.3300

  20. Oncology Adaptive Trial Design

    Classical and Adaptive Clinical Trial Designs using Expdesign Studio

    Mark Chang, Pages: 123–148, 2008

    Published Online : 11 JUL 2008, DOI: 10.1002/9780470368718.ch7